Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be readily isolated from many adult tissues. They can differentiate into different cell types of the mesodermal lineage, such as adipocytes, osteoblasts and chondrocytes.^[@bib1]^ In addition to their multipotentiality, MSCs can interact with various immune cells, including T lymphocytes,^[@bib2]^ macrophages,^[@bib3]^ and modulate both innate and adaptive immune responses.^[@bib4]^ These unique properties prompt increasing clinical applications of MSCs in the field of regenerative medicine^[@bib5]^ and in the treatment of autoimmune and infectious diseases.^[@bib6]^

Recent studies demonstrate that biological functions of MSCs are largely dependent on distinct pattern recognition receptors (PRRs),^[@bib7],\ [@bib8],\ [@bib9]^ which can be activated by various pathogen-associated molecular patterns (PAMPs), such as bacterial lipopolysaccharide (LPS), and viral double-stranded RNA (dsRNA). For example, LPS activates Toll-like receptor (TLR) 4 and increases osteogenic differentiation of MSCs,^[@bib8]^ whereas dsRNA activates TLR3 and promotes MSC migration,^[@bib10]^ and enhances the immunomodulatory activity of MSCs in sustaining the neutrophil function.^[@bib11]^ To date, TLRs (TLR2, TLR3 and TLR4) ^[@bib7],\ [@bib8]^ and nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) (NOD1 and NOD2) ^[@bib9]^ have been identified as functional PRRs in MSCs. Nonetheless, nothing is known regarding the expression and function of retinoic acid inducible gene I (RIG-I)-like receptors (RLRs) in MSCs.

As a common viral PAMP, dsRNA has been demonstrated to modulate several biological functions of MSCs.^[@bib8],\ [@bib11],\ [@bib12]^ This non-self-RNA can be recognized by distinct PRRs and initiates innate antiviral responses.^[@bib13]^ Whereas extracellular dsRNA accesses to endosome by endocytosis and activates TLR3 on the endosomal membrane,^[@bib14],\ [@bib15]^ cytosolic dsRNA is recognized by RLRs in the cytosol.^[@bib16]^

RIG-I and melanoma differentiation-associated antigen 5 (MDA5) are well-characterized RLR family members and selectively recognize short and long dsRNA, respectively.^[@bib17]^ Upon recognition of dsRNA, RLRs associate with a common adaptor protein, interferon (IFN)-*β* promoter stimulator 1 (IPS-1), which subsequently activates TANK-binding kinase 1 (TBK1), I*κ*B kinase epsilon (IKK*[ɛ]{.ul}*) and IKK*α/β*.^[@bib18]^ The RLR signaling finally results in the activation of transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor *κ*B (NF-*κ*B) for the induction of type I IFNs and pro-inflammatory cytokines such as interleukin 6 (IL-6). Type I IFNs secreted by viral-infected cells induce the expression of many antiviral interferon-stimulated genes (ISGs), which can restrict virus replication by degrading viral RNA, inhibiting protein synthesis or inducing cell apoptosis. Therefore, the synthetic dsRNA analog polyinosinic polycytidylic acid (poly(I:C)) is widely used as an adjuvant in prophylaxis and treatment of viral infection.^[@bib19],\ [@bib20]^ However, the role of PRRs and PAMPs in the survival of MSCs is largely unknown.

During viral infection or dsRNA stimulation, RLRs have been demonstrated to participate in apoptosis.^[@bib21],\ [@bib22],\ [@bib23]^ RLR signaling can directly induce several pro-apoptotic molecules, such as phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1, also known as NOXA),^[@bib21],\ [@bib24]^ a BH3-only protein that initiates an intrinsic apoptotic signaling. RLR-induced type I IFNs can initiate or facilitate a pro-apoptotic signaling by inducing some ISGs, including RNA-activated protein kinase (PKR).^[@bib25],\ [@bib26]^ In addition, activation of RLRs induces the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), resulting in the initiation of the extrinsic apoptotic pathway in an autocrine manner.^[@bib27],\ [@bib28]^ In addition to apoptosis, recent studies reveal that RLRs also mediate another cellular stress response, autophagy,^[@bib29]^ which is a ubiquitous cytosolic homeostasis process in all eukaryotes. Autophagy is rapidly activated in response to extracellular stress, such as starvation, hypoxia and infection.^[@bib30]^ In most cases, autophagy constitutes an essential mechanism of adaptation to external or internal stress to avoid cell death.^[@bib31]^ However, massive and extensive autophagy may act as a programmed cell death mechanism and result in autophagic cell death.^[@bib32]^

In this study, we tested the effect of various PAMPs on the survival of MSCs. Our data demonstrate that activation of TLRs 1--9 has little effect on the survival of MSCs, whereas activation of RIG-I and MDA5 by transfected dsRNA results in marked cell death. Transfected dsRNA induces both extrinsic and intrinsic apoptotic responses via RLR signaling, independently of autocrined IFN-*β*. In addition, potent autophagy is triggered in MSCs upon RLR activation but is not responsible for RLR-mediated cell death. Our findings first explore the existence of functional RLRs in MSCs and demonstrate their potential role in controlling the MSC survival, which may provide a better understanding of MSC response to viral infection.

Results
=======

Transfection of poly(I:C) induces cell death of MSCs
----------------------------------------------------

To test whether PRRs have effect on the survival of MSCs, cells were stimulated with indicated PAMPs, and cell viability was examined by using an MTT assay. Activation of TLR2/6, TLR1/2, TLR4, TLR5, TLR7/8 or TLR9 did not reduce the viability of MSCs ([Figure 1a](#fig1){ref-type="fig"}), whereas activation of TLR3 by adding poly(I:C) with a high molecular weight (poly(I:C)-HMW) or low molecular weight (poly(I:C)-LMW) into the culture media slightly decreased the MSC viability at a concentration of 25 *μ*g/ml ([Figure 1a](#fig1){ref-type="fig"}). We further detected the cell viability by using Annexin V/PI staining and flow cytometry analysis. Consistently, stimulation with TLR ligands did not result in cell death of MSCs, except for activation of TLR3 by poly(I:C)-HMW or -LMW led to 5% cell death of MSCs ([Figure 1b](#fig1){ref-type="fig"}). Futhermore, we delivered poly(I:C) into cytosol of MSCs by lipofectin transfection. Both poly(I:C)-HMW and -LMW transfection markedly decreased the viability of MSCs in a dose-dependent manner ([Figure 1c](#fig1){ref-type="fig"}). Flow cytometry analysis associated with Annexin V/PI staining showed that more than 35% of MSCs died in the presence of 1 *μ*g/ml poly(I:C) at 12 h post transfection ([Figure 1d](#fig1){ref-type="fig"}). Morphologically, poly(I:C) transfection induced the adherent cells to round up and detach from the culture dish ([Figure 1e](#fig1){ref-type="fig"}). These results indicate that transfection of poly(I:C) induces cell death of MSCs.

Transfection of poly(I:C) upregulates RIG-I and MDA5 in MSCs
------------------------------------------------------------

As transfection of poly(I:C) activates cytosolic RLRs, we further detected the expression of RIG-I and MDA5 after poly(I:C) transfection. Real-time PCR data showed that both poly(I:C)-HMW and -LMW transfection upregulated the mRNA expression of RIG-I in a time-dependent manner, peaked at 12 h post transfection ([Figure 2a](#fig2){ref-type="fig"}). The mRNA expression level of MDA5 in poly(I:C)-transfected MSCs was ∼35-fold higher at 4 h post transfection, when compared with unstimulated MSCs ([Figure 2b](#fig2){ref-type="fig"}). However, no change in expression of RIG-I ([Figure 2c](#fig2){ref-type="fig"}) or MDA5 ([Figure 2d](#fig2){ref-type="fig"}) was detected after addition of poly(I:C)-HMW or -LMW at 100 ng/ml to the culture media of MSCs. Consistent with mRNA expression, both RIG-I and MDA5 were robustly upregulated at protein level after transfection of poly(I:C) ([Figure 2e](#fig2){ref-type="fig"}) but not addition of poly(I:C) ([Figure 2f](#fig2){ref-type="fig"}), as determined by western blot.

RLR stimulation induces activation of IRF3 and NF-*κ*B in MSCs
--------------------------------------------------------------

To investigate the functionality of RLRs in MSCs, we stimulated MSCs by transfection of poly(I:C) to activate RLR signaling and examined the phosphorylation of IRF3 and nuclear translocation of NF-*κ*B. Western blot data showed that both poly(I:C)-HMW and -LMW transfection led to the phosphorylation of IRF3 in a time-dependent manner ([Figure 3a](#fig3){ref-type="fig"}). However, direct addition of poly(I:C) at 100 ng/ml to the culture media of MSCs failed to induce phosphorylation of IRF3 ([Figure 3b](#fig3){ref-type="fig"}). Furthermore, nuclear translocation of NF-*κ*B p65 subunit in poly(I:C)-HMW and -LMW *versus* mock-transfected MSCs was visualized by immunofluorescence microscopy. In mock-treated MSCs, positive staining for NF-*κ*B p65 subunit was mainly distributed in the cytoplasm, whereas, in poly(I:C)-HMW and -LMW-transfected MSCs, NF-*κ*B p65 protein aggregated in the nuclei of MSCs ([Figure 3c](#fig3){ref-type="fig"}). In addition, in MSCs directly stimulated with poly(I:C), no nuclear translocation of the NF-*κ*B p65 subunit was observed ([Figure 3d](#fig3){ref-type="fig"}). Collectively, these data indicate that RLRs stimulation in MSCs results in the activation of downstream IRF3 and NF-*κ*B signaling pathways.

Activation of RLRs triggers the expression of IFN-*β* and IL-6 in MSCs
----------------------------------------------------------------------

We further used real-time PCR to detect the expression of IFN-*β* and pro-inflammatory cytokine IL-6, which are downstream effector genes of RLR signaling. IFN-*β* was induced in a dose-dependent manner in MSCs transfected with either poly(I:C)-HMW or -LMW ([Figure 4a](#fig4){ref-type="fig"}). IFN-*β* expression increased rapidly after poly(I:C) transfection as early as 1 h post treatment, peaking at 8 h post treatment ([Figure 4b](#fig4){ref-type="fig"}). However, stimulation of MSCs by addition of poly(I:C) to culture media did not induce IFN-*β* expression ([Figures 4c and d](#fig4){ref-type="fig"}). ELISA data further confirmed that transfection of poly(I:C) induced the production of IFN-*β* in a time-dependent manner ([Figure 4e](#fig4){ref-type="fig"}). In addition, mRNA expression of pro-inflammatory cytokine IL-6 was increased after poly(I:C) transfection ([Figure 4f](#fig4){ref-type="fig"}) but not addition to culture media ([Figure 4g](#fig4){ref-type="fig"}). ELISA data showed that production of IL-6 was enhanced in MSCs after poly(I:C) transfection ([Figure 4h](#fig4){ref-type="fig"}). To further confirm the functionality of RLRs in MSCs, RNA interference technique was used to knockdown endogenous expression of RIG-I and MDA5. The silencing efficiency of siRIG-I and siMDA5 was confirmed by western blot ([Figure 4i](#fig4){ref-type="fig"}). Both real-time PCR and ELISA data indicated that silencing of RIG-I decreased IFN-*β* and IL-6 induction in poly(I:C)-LMW-transfected cells, whereas silencing of MDA5 had no significant effects on LMW-induced IFN-*β* or IL-6 production ([Figure 4j](#fig4){ref-type="fig"}). In contrast, both IFN-*β* and IL-6 induction by HMW transfection was reduced by siMDA5 but not siRIG-I ([Figure 4j](#fig4){ref-type="fig"}). These results suggest that transfection of poly(I:C)-LMW and -HMW in MSCs activates RIG-I and MDA5, respectively. Together, these data indicate that both RIG-I and MDA5 are functionally expressed in MSCs. We further tested the involvement of TBK1/IKK*ɛ*/IRF3 and IKKα/β/NF-*κ*B signaling pathways in RLR-mediated cytokine production. Inhibition of TBK1/IKK*ɛ* with BX795 attenuated IFN-*β* production induced by poly(I:C) transfection but had little effect on the induction of IL-6 ([Figure 4k](#fig4){ref-type="fig"}). In contrast, the production of IL-6 in poly(I:C)-transfected MSCs was significantly reduced after blocking NF-*κ*B signaling with an IKK*α/β* inhibitor BMS-345541, whereas no difference was detected in IFN-*β* production ([Figure 4k](#fig4){ref-type="fig"}). These results suggest that TBK1/IKK*ɛ*/IRF3 signaling mediated the induction of IFN-*β* in poly(I:C)-transfected MSCs, whereas IKK*α/β*/NF-*κ*B signaling mediated the induction of IL-6.

Activation of RLRs induces apoptosis in MSCs
--------------------------------------------

To determine whether apoptosis is involved in poly(I:C)-induced cell death of MSCs, we detected the cleavage of Caspase-3 and its substrate poly (ADP-ribose) polymerase (PARP), which are specific hallmarks of apoptotic cell death. Western blot data showed that poly(I:C) transfection led to the cleavage of Caspase-3 and PARP in MSCs in a time- and dose-dependent manner ([Figures 5a and b](#fig5){ref-type="fig"}), indicating the activation of apoptosis. However, direct addition of poly(I:C) to culture media at a concentration as high as 25 *μ*g/ml induced weak apoptosis of MSCs, suggesting that efficient apoptosis induction of dsRNA in MSCs required cytosolic delivery ([Figure 5c](#fig5){ref-type="fig"}). Furthermore, in LMW-treated MSCs, knockdown of RIG-I significantly inhibited cell apoptosis, whereas HMW-induced apoptosis was reduced by silencing of MDA5 ([Figure 5d](#fig5){ref-type="fig"}), suggesting that RLRs mediated pro-apoptotic signaling induced by cytosolic dsRNA. Interestingly, ectopic expression of RIG-I or MDA5 without poly(I:C) transfection did not induce the cleavage of Caspase-3 or PARP ([Figure 5e](#fig5){ref-type="fig"}). However, overexpression of RIG-I in MSCs promoted LMW-induced apoptosis, whereas overexpression of MDA5 enhanced HMW-induced apoptosis ([Figure 5e](#fig5){ref-type="fig"}). We also found that inhibition of TBK1/IKK*ɛ* increased poly(I:C)-induced apoptosis of MSCs, whereas IKK*α/β* inhibitor rescued MSCs from apoptosis ([Figure 5f](#fig5){ref-type="fig"}). These results indicate that IKK*α/β* mediates a pro-apoptotic signaling, whereas TBK1/IKK*ɛ* serves a pro-survival role. We also tested the cleavage of Caspase-8 and Caspase-9, which are initiator caspases of extrinsic and intrinsic apoptotic pathways, respectively. Transfection of HMW or LMW into MSCs resulted in the cleavage of both Caspase-8 and Caspase-9 ([Figure 5g](#fig5){ref-type="fig"}), indicating RLR stimulation activated both extrinsic and intrinsic apoptotic pathways. Furthermore, overexpression of Bcl2 ([Figure 5h](#fig5){ref-type="fig"}) or blockage of IFN-*β* with a neutralizing antibody ([Figure 5i](#fig5){ref-type="fig"}) had little effect on poly(I:C)-induced apoptosis of MSCs, suggesting that the poly(I:C)-induced apoptosis is independent of Bcl2 and IFN-*β*.

Activation of RLRs induces autophagy but not autophagic cell death in MSCs
--------------------------------------------------------------------------

In addition to apoptosis, activation of RLRs by transfection of dsRNA induces autophagy, another cellular stress response that may result in autophagic cell death ultimately. Western blot data showed that transfection with either poly(I:C)-HMW or -LMW resulted in a conversion from LC3 I to LC3 II ([Figure 6a](#fig6){ref-type="fig"}), indicating the induction of autophagy in MSCs. Moreover, the autophagic response in MSCs was monitored by monodansylcadaverine (MDC) staining, a specific autophagosome indicator. Accumulation of MDC-positive autophagosome was observed in poly(I:C)-transfected MSCs ([Figure 6b](#fig6){ref-type="fig"}). In addition, immunofluorescence microscopy showed that stimulation of MSCs with poly(I:C) led to redistribution of LC3 from a diffuse to punctate pattern, which is characteristic of autophagosomes ([Figure 6c](#fig6){ref-type="fig"}). Altogether, these data above indicate that autophagy is induced in MSCs upon RLR activation.

Furthemore, to determine whether autophagy mediates dsRNA-induced cell death of MSCs, 3-methyladenine (3-MA), LY294002 (LY) or Wortmannin (WM) was used to block the autophagic response in MSCs. Western blot data showed that all three inhibitors were able to block dsRNA-induced autophagy ([Figure 6d](#fig6){ref-type="fig"}). However, none of them had significant impact on dsRNA-induced MSCs cell death ([Figure 6e](#fig6){ref-type="fig"}). Similarly, silencing of *Beclin1*, a key autophagy-related gene, markedly decreased the expression levels of LC3 II but not cleaved Caspase-3 or PARP, suggesting that knockdown of Beclin1 led to the blockage of autophagic but not apoptotic response in MSCs ([Figure 6f](#fig6){ref-type="fig"}). In addition, knockdown of Beclin1 failed to rescue MSCs from dsRNA-induced cell death ([Figure 6g](#fig6){ref-type="fig"}), indicating that, although autophagy is robustly induced in MSCs upon activation of RLR signaling, it is not responsible for RLRs-mediated cell death of MSCs.

Discussion
==========

MSCs acquire great interests recently for their potential application in clinical therapy of injury and immune-related disorders due to their regenerative^[@bib5]^ and immunosuppressive properties.^[@bib33]^ The biological activities of MSCs, including differentiation,^[@bib7],\ [@bib8]^ migration and immunomodulation,^[@bib10]^ are largely determined by various functional PRRs that recognize either extracellular or cytosolic signals.

RLRs are cytosolic RNA helicases responsible for recognizing viral PAMPs such as dsRNA.^[@bib16]^ In the present study, we identify the existence of functional RLRs in MSCs for the first time. Both RIG-I and MDA5 are constitutively expressed in MSCs and upregulated after dsRNA transfection. Activation of RIG-I and MDA5 by dsRNA transfection induces phosphorylation of IRF3, nuclear translocation of NF-*κ*B and expression of IFN-*β* and IL-6, indicating that RLRs expressed in MSCs are functional.

Previous studies have identified other functional PRRs in MSCs, including TLR2, TLR3 and TLR4, which have a critical role in modulating proliferation, differentiation,^[@bib7],\ [@bib8]^ migration and immunoregulatory activity.^[@bib10]^ However, whether PRRs influence the MSC survival remains unknown. It is reported that TLRs differentially regulate cell death of several other cell types. For example, activation of TLR2 triggers microglial cell death^[@bib34]^ but does not lead to cell death in B lymphocytes.^[@bib35]^ TLR4 activation reduces the survival of intestinal stem cells^[@bib36]^ but promotes cancer cell survival in hepatocellular carcinoma.^[@bib37]^ These reports suggest that TLRs induce cell death in a context-dependent manner. Our study shows that activation of RLRs markedly reduces the viability of MSCs, whereas activation of TLRs has no influence on MSC survival, except for TLR3 activation induces a slight decrease in cell viability, indicating that RLR signaling is critical in controlling MSC survival. To the best of our knowledge, this is the first study to explore the role of PRRs in regulating the survival of MSCs.

Apoptosis is a common type of programmed cell death that largely influences cell viability. It is reported that serum deprivation and hypoxia can induce the apoptotic response in MSCs.^[@bib38]^ However, which PRR participates in modulating MSC apoptosis is still unclear. Our study demonstrates that transfection of dsRNA results in the cleavage of apoptotic marker Caspase-3 and PARP in MSCs, whereas addition of dsRNA only slightly induces apoptotic response till reaching a concentration as high as 25 *μ*g/ml. This observation is consistent with other study showing the marked difference in caspase activation and apoptoic response in extracellular *versus* cytosolic dsRNA-stimulated human macrophages or keratinocytes.^[@bib39]^ It is well known that dsRNA with different length could be recognized by distinct RNA sensors. Experimentally, transfection of short or long dsRNA activates the cytosolic receptor RIG-I and MDA5, respectively,^[@bib17]^ whereas addition of both types of dsRNA activated TLR3 expressed on the endosomal membrane.^[@bib14],\ [@bib15]^ Studies have demonstrated that RLR activation induces rapid apoptosis in various cancer cell types, such as human melanoma cells.^[@bib22]^ In the present study, knockdown of endogenous RLRs attenuates the dsRNA-induced apoptosis in MSCs, further confirming that the pro-apoptotic effect of cytosolic dsRNA is RLR-dependent. Previous studies showed that knockout of RIG-I or MDA5 impaired the production of IFN-*β* and antiviral defense after infection with RNA viruses.^[@bib40]^ Ectopic expression of RIG-I did not result in the induction of IFN-*β* but enhanced the induction of IFN-*β* after either dsRNA transfection or RNA virus infection.^[@bib41]^ Similarly, in our study, ectopic expression of RIG-I or MDA5 is not sufficient to induce apoptosis of MSCs but increases apoptosis induced by dsRNA transfection.

The IKK-related kinases, TBK1 and IKK*[ɛ]{.ul}*, are well-characterized regulators of the innate immune response because of their abilities to phosphorylate transcription factor IRF3.^[@bib42]^ Recent evidence showed that both TBK1 and IKK*[ɛ]{.ul}* contribute to cell survival.^[@bib43]^ TBK1 suppresses apoptosis in oncogenic KRAS-transformed cells,^[@bib44]^ while IKK*[ɛ]{.ul}* is required for the survival of MCF-7 breast cancer cells.^[@bib45]^ Our results show that inhibition of TBK1/IKK*[ɛ]{.ul}* significantly increased the dsRNA-induced MSC apoptosis, suggesting the critical pro-survival role of TBK1/IKK*[ɛ]{.ul}* in MSCs. Studies have demonstrated that NF-*κ*B functions to promote resistance to cell death through induction of antiapoptotic genes^[@bib46]^ but may also promote apoptosis under certain circumstances.^[@bib47],\ [@bib48]^ In this study, we found that poly(I:C)-induced apoptosis of MSCs is reduced upon suppression of IKK*α[/]{.ul}β*, suggesting the pro-apoptotic role of NF-*κ*B signaling in MSCs.

Studies have revealed that RLR signaling triggers either extrinsic or intrinsic apoptotic pathways. For example, in human melanoma cells, RLR signaling induced the pro-apoptotic BH3-only proteins Puma and Noxa independently of type I IFNs and resulted in efficient activation of intrinsic apoptosis.^[@bib22]^ Whereas in Sendai virus-infected prostate cancer cells^[@bib28]^ or dsRNA-transfected breast cancer cells,^[@bib49]^ both extrinsic and intrinsic apoptotic signaling pathways are initiated by RLR activation. In our study, activation of RLR signaling triggers cleavage of both Caspase-8 and Caspase-9, indicating RLRs mediate both extrinsic and intrinsic apoptosis. However, overexpression of Bcl2, a key antiapoptotic molecule regulator of the intrinsic apoptotic pathway, does not reduce apoptosis in poly(I:C)-transfected MSCs, indicating that the intrinsic pathway has a minor role in the poly(I:C)-induced apoptosis in MSCs. In addition, activation of RLRs leads to robust production of IFN-*β*, which may be involved in modulating cell apoptosis. For instance, modified Vaccinia virus Ankara infection activated cytosolic RLRs to initiate apoptosis in an IFN-*β*-dependent manner.^[@bib21]^ However, in our study, blocking IFN-*β* with a eutralizing antibody do not rescue MSCs from RLR-mediated apoptosis, suggesting the autocrined IFN-*β* do not mediate cytosolic dsRNA-induced apoptosis of MSCs. This finding is consistent with other studies showing that activation of RLRs induces apoptotic response independently of type I IFN in human melanoma cells^[@bib22]^ or in the absence of type I IFN receptor.^[@bib50]^

In addition to apoptosis, autophagy is another cellular stress response that is related to cell survival. It is reported that dsRNA transfection induces apoptosis of breast cancer cells, which is accompanied by autophagy.^[@bib49]^ Our study demonstrates that activation of RLR signaling by transfected dsRNA triggers both apoptotic and autophagic responses. Autophagy is an evolutionarily conserved self-digestion process and constitutes a stress adaptation that protects cells against death. However, it may also serve as an alternative cell death pathway, designated as autophagic cell death. Tormo *et al.* report that in melanoma cells, transfected dsRNA induces autophagy via RLR signaling, which in turn leads to dramatic autophagic cell death.^[@bib29]^ Whereas Inao *et al.* demonstrates that autophagy plays a cytoprotective role in human breast cancer cells by suppressing the dsRNA-induced apoptosis.^[@bib49]^ In the present study, we find that, although autophagy is induced after dsRNA transfection, it does not influence the dsRNA-induced cell death or apoptosis in MSCs. On the basis of literature, induction of autophagy is beneficial for clearance of some intracellular pathogens such as viruses;^[@bib51]^ thus, we hypothesize that the cytosolic dsRNA-triggered autophagic response may have an important role in the antiviral response by MSCs, which needs further investigation.

Several clinical investigations reveal the susceptibility of MSCs to a variety of viruses, such as human immunodeficiency virus-1 (HIV-1).^[@bib52]^ It is reported that purified genomic RNA from HIV is sensed by RIG-I,^[@bib53]^ which may explain the observation of HIV-1-induced apoptosis in MSCs.^[@bib52]^ Therefore, our work has important implication for understanding the pathogenesis of viral infection in MSCs.

In summary, our study first explores the expression and function of RLRs in MSCs. We demonstrate that transfected dsRNA activates cytosolic RLR signaling and induces expression of IFN-*β* and pro-inflammatory cytokine IL-6. Moreover, activation of RLR signaling by cytosolic dsRNA triggers marked apoptotic response independently of INF-*β*. In addition, autophagic response is triggered in MSCs upon RLR activation but not responsible for RLR-mediated cell death. Altogether, our data provide a better understanding of RLRs in regulating the survival of MSCs, which may gain further insights into the pathogenesis of viral infection in MSCs.

Materials and Methods
=====================

Reagents
--------

Synthetic bacterial lipoprotein Pam2CSK4, Pam3CSK4, synthetic dsRNA mimic poly(I:C)-HMW or -LMW, LPS (from *E. coli* 0111:B4 ), ultrapure flagellin (from *S. typhimurium*), R848, synthetic CpG oligonucleotide (ODN 1668) [and TBK1/IKK]{.ul}*[ɛ]{.ul}*[inhibitor (BX795)]{.ul} were purchased from Invivogen (San Diego, CA, USA). [IKK]{.ul}*α[/]{.ul}β* [inhibitor (BMS-345541)]{.ul}, LY294002, Wortmannin were from Merck Millipore (Darmstadt, Germany). Monodansylcadaverine (MDC), 3-methyladenine, anti-*β*-actin antibody and rabbit IgG were from Sigma (St. Louis, MO, USA). Anti-RIG-I, anti-MDA5, anti-cleaved Caspase-3, anti-cleaved PARP, anti-cleaved Caspase-8, anti-cleaved Caspase-9 and anti-phosphorylated IRF3 antibodies were obtained from Cell Signaling Technology (Beverly, MA, USA). Anti-NF-*κ*B p65 and anti-IRF3 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-LC3 antibody was from Novus Biologicals (Littleton, CO, USA). Anti-Beclin1 antibody was from R&D Systems (Minneapolis, MN, USA). Anti-IFN-*β* neutralizing antibody was from PBL interferon source (Piscataway, NJ, USA). Anti-Bcl2 antibody was from R&D systems (Minneapolis, MN, USA).

Cell culture
------------

MSCs were obtained from bone marrow of tibia and femur of 6- to 8-week-old C57BL/6 mice as described previously.^[@bib54]^ Cells were cultured in DMEM low-glucose medium supplemented with 10% FBS, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin (all from Invitrogen, Carlsbad, CA, USA). The isolated MSCs were immunophenotyped by flow cytometry as reported previously.^[@bib54]^ MSCs from Passage 5 to 20 were used in all experiments. All experiments involving animals were approved by the Animal Ethics Committee of Sun Yat-Sen University.

Cell stimulation
----------------

To stimulate TLRs 1--9, their respective ligands were added directly into the culture media. To stimulate RIG-I and MDA5, poly(I:C)-HMW or -LMW was delivered into cytoplasm of MSCs by using Lipofectamine 2000 (Invitrogen) according to the manufacturer\'s protocol. For mock transfection, no synthetic poly(I:C) was used in the procedure.

siRNA knockdown
---------------

All siRNAs targeting specific genes of interest were obtained from Invitrogen, and scrambled siRNA (siNC) was used as negative control. The target sequences of siRNAs used in the present study were as follows: RIG-I siRNA (siRIG-I), 5′-GCCCAUUGAAACCAAGAAAUU-3′ MDA5 siRNA (siMDA5), 5′-GUCAUUAGUAAAUUUCGCACU-3′ Beclin1 siRNA (siBeclin1), 5′-CAGUUUGGCACAAUCAAUA-3′. For knockdown experiments, cells were transfected with siRNA (100 nM) for 48 h using Lipofectamine 2000 (Invitrogen) according to the manufacturer\'s protocol.

Plasmid
-------

To generate Bcl2 expression vector, full-length mouse Bcl2 was amplified with PCR and cloned into pcDNA3. pcDNA3-mRIG-I and pcDNA3 were provided by Professor Baoxue Ge (Tongji University, Shanghai, China). pUNO1-mcs and pUNO1-mMDA5 were purchased from Invivogen. Transfection of plasmid was performed using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer\'s instructions.

Real-time PCR
-------------

Total RNA was isolated with TRIzol reagent (Invitrogen) according to the manufacturer\'s instruction. First-strand cDNA synthesis was performed using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, MA, USA). The cDNA was quantitated in duplicate using SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA) as reported.^[@bib55]^ The specificity of the amplified PCR products was assessed by melting curve analysis. Relative mRNA levels were calculated after normalization to *β*-actin. The sequences of primers for RIG-I, MDA5 and IFN-*β* are as following: RIG-I, forward, 5′-GACGTTCGAGATTCCAGTCAT-3′, and reverse, 5′-GCATTGGCTCATCAACTCCAT-3′ MDA5, forward, 5′-ACCAGATCCCCTGAAGTTGGAGT-3′, and reverse, 5′-GGAAGAAGGGTGAACTGAGGAGATG-3′ IFN-*β*, forward, 5′-GGAGATGACGGAGAAGATGCAGA-3′, and reverse, 5′-GGAGTTCATCCAGGAGACGTACA-3′. Other primers used in the present study were described previously.^[@bib56],\ [@bib57]^

Enzyme-linked immunosorbent assay
---------------------------------

Supernatants from cultured MSCs were collected, and cytokine protein levels were tested using ELISA kits (PBL interferon source Verikine Mouse IFN-*β* ELISA kit and eBioscience Mouse IL-6 Platinum ELISA kit) according to the manufacturer\'s instructions. The limits of detection of IFN-*β* and IL-6 are 15.6 and 6.5 pg/ml, respectively.

Western blot
------------

Western blot was performed as described previously.^[@bib58]^ Briefly, 20 μg proteins were separated on SDS-PAGE, transferred to polyvinylidene difluoride membrane, blocked with 5% (w/v) nonfat milk and then probed with the indicated primary antibody. Western blots were developed using horseradish peroxidase-conjugated secondary antibody, followed by detection with enhanced chemiluminescence.

Immunofluorescence microscopy
-----------------------------

Cells were seeded onto coverslips and treated with poly(I:C) or mock transfection as mentioned above and then fixed with 4% paraformaldehyde, permeabilized with 0.05% Triton X-100 and blocked with 5% BSA in PBS. Samples were incubated with a primary antibody at 4 °C overnight, rinsed three times with PBS and then incubated with Alexa Fluor 488 Goat Anti-Rabbit IgG (Invitrogen) for 1 h at room temperature. Coverslips were washed twice before 4,6-diamidino-2-phenylindole (DAPI) staining and mounted with ProLong Gold antifade reagent (Invitrogen). Stained samples were visualized using an Olympus BX53 fluorescence microscope (Olympus Corporation, Tokyo, Japan).

Cell viability assay
--------------------

Cell viability was assessed by using an MTT assay in triplicate. In brief, one-tenth volume of 5 mg/ml MTT solution was added into cultured media and allowed to incubate for 4 h at 37 °C in dark. The violet formazan crystal was dissolved in dimethyl sulfoxide (DMSO) and the absorbance was measured at 490 nm.

Annexin V/propidium iodide staining
-----------------------------------

MSCs were treated with indicated ligand for 12 h, then collected, resuspended in binding buffer and stained with Annexin V-FITC and propidium iodide (KeyGEN Biotech, Nanjing, China) according to the manufacturer\'s instructions. The stained cells were analyzed with flow cytometry (Beckman Coulter EPICS XL/MCL, Fullerton, CA, USA). Data were analyzed with Flowjo Software (Tree Star, Ashland, OR, USA).

Statistical analysis
--------------------

Experiments were performed in duplicate or triplicate for at least three times independently. GraphPad Prism 4.0 (GraphPad Software, San Diego, CA, USA) was used for statistical analysis. The differences between two groups were compared by using an unpaired two-tailed Student\'s *t*-test, while differences between three groups or more were compared by using analysis of variance (ANOVA) with Bonferroni\'s *post hoc* test. Differences were considered statistically significant with a *P*-value less than 0.05.

This work was supported by grants National Natural Science Foundation of China (U0832006, 31200662, 81261160323), Guangdong Innovative Research Team Program (No. 2009010058), Specialized Research Fund for the Doctoral Program of Higher Education of China (20100171110047, 20120171120064), Guangdong Natural Science Foundation (10251008901000013, S2012040006680), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (No. 2009), National Science and Technology Key Projects for Major Infectious Diseases (2013ZX10003001), The 111 Project (No. B13037).

MSCs
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:   pattern recognition receptors
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:   Toll-like receptor

PAMPs

:   pathogen-associated molecular patterns
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:   double-stranded RNA
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:   nucleotide binding and oligomerization domain (NOD)-like receptor
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:   retinoic acid inducible gene I
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:   RIG-I-like receptor
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:   melanoma differentiation-associated antigen 5

IFN

:   interferon

IPS-1

:   interferon (IFN)-*β* promoter stimulator 1

TBK1

:   TANK-binding kinase 1

IKK

:   I*κ*B kinase

IRF3

:   interferon regulatory factor 3

NF-*κ*B

:   nuclear factor *κ*B

ISGs

:   interferon-stimulated genes

PKR

:   RNA-activated protein kinase

Bcl2

:   B-cell lymphoma 2

poly(I:C)

:   polyinosinic polycytidylic acid

siRNA

:   small interference RNA
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:   4,6-diamidino-2-phenylindole

PI

:   propidium iodide

PARP

:   poly (ADP-ribose) polymerase

HIV-1

:   human immunodeficiency virus-1
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![Effect of PRR activation on the survival of MSCs. Individual PAMP was added into the culture media of MSCs at indicated concentrations, and the cell viability was measured by using an MTT assay (**a**) and flow cytometry analysis with Annexin V/PI staining (**b**). Poly(I:C)-HMW or -LMW was transfected into MSCs, and the cell viability was measured by using an MTT assay (**c**) and flow cytometry analysis with Annexin V/PI staining (**d**). MTT assay data are shown as mean±S.E.M. of three independent experiments. Flow cytometric data are representative of three independent experiments with similar results. MSCs were transfected with poly(I:C)-HMW or -LMW (0.5 *μ*g/ml) and examined under a microscope and photographed at 24 h post treatment (**e**). Arrows denote rounding and detaching dead cells](cddis2013504f1){#fig1}

![Transfection of poly(I:C) upregulates RIG-I and MDA5 in MSCs. MSCs were transfected or added with poly(I:C)-HMW or -LMW at 100 ng/ml for the indicated time. mRNA expression levels of RIG-I (**a** and **c**) and MDA5 (**b** and **d**) were analyzed by real-time PCR. Data are shown as mean±S.E.M. of three independent experiments. The protein expression levels of RIG-I and MDA5 were analyzed by western blot in MSCs after poly(I:C) transfection (**e**) or addition (**f**). Data are representative of three independent experiments with similar results](cddis2013504f2){#fig2}

![Activation of RLRs induces activation of IRF3 and NF-*κ*B in MSCs. Poly(I:C)-HMW or -LMW (100 ng/ml) was transfected into MSCs (**a**) or added to the culture media (**b**) for the indicated time, and the phosphorylation of IRF3 was detected by western blot. The nuclear translocation of NF-*κ*B p65 subunit (green) was monitored by immunofluorescence microscopy after poly(I:C) transfection (**c**) or addition (**d**). Nuclei were visualized by DAPI staining (blue). Data are representative of three independent experiments with similar results](cddis2013504f3){#fig3}

![Activation of RLRs induces the expression of IFN-*β* and IL-6. Poly(I:C)-HMW or -LMW was transfected into MSCs or added to the culture media for the indicated concentration or time. mRNA levels of IFN-*β* (**a**--**d**) and IL-6 (**f** and **g**) were analyzed by real-time PCR. Protein levels of IFN-*β* (**e**) and IL-6 (**h**) in supernatants of poly(I:C)-transfected MSCs were measured by ELISA. MSCs were transfected with siRNA targeting RIG-I and MDA5 for 48 h (**i** and **j**), or pretreated with inhibitors for TBK1/IKK*[ɛ]{.ul}* (BX795, 1 *μ*M) or IKK*α[/]{.ul}β* (BMS-345541,10 *μ*M) for 1 h (**k**), followed by poly(I:C) transfection. The knockdown efficacy was confirmed by western blot (**i**). mRNA and protein levels of IFN-*β* and IL-6 were detected by real-time PCR and ELISA, respectively (**j** and **k**). Data are shown as mean±S.E.M. of three independent experiments. \*\**P*\<0.01; \*\*\**P*\<0.001; NS, not significant](cddis2013504f4){#fig4}

![Activation of RLRs induces apoptosis in MSCs. Apoptosis signaling-related molecules in MSCs were tested by western blot. MSCs were transfected with poly(I:C) (HMW or LMW, 200 ng/ml) for the indicated time (**a**) or for 6 h at the indicated concentration (**b**). MSCs were stimulated with poly(I:C) complexed with or without Lipofectemine 2000 for 6 h (**c**). MSCs were transfected with siRNA targeting RIG-I and MDA5 (**d**) or expressing plasmid of RIG-I, MDA5 (**e**) or Bcl2 (**h**), followed by poly(I:C) transfection (200 ng/ml) for 6 h. MSCs were pretreated with inhibitors for TBK1/IKK*ɛ* (BX795, 1 *μ*M) or IKK*α/β* (BMS-345541, 10 *μ*M) (**f**), or incubated with 500 U/ml anti-IFN-*β* neutralizing antibody (*α*-IFN-*β*) (**i**), followed by poly(I:C) transfection (200 ng/ml) for 6 h. MSCs were transfected with poly(I:C) at the indicated concentration for 6 h (**g**). Data are representative of three independent experiments with similar results](cddis2013504f5){#fig5}

![RLR stimulation activates autophagy but not autophagic cell death in MSCs. MSCs were transfected with poly(I:C) (HMW or LMW, 200 ng/ml) or mock treated for 6 h. (**a**) Protein levels of LC3 I and LC3 II were analyzed by western blot. (**b**) Autophagic vacuoles were stained by using monodansylcadaverine (MDC) for 30 min and visualized with fluorescence microscopy. (**c**) The distribution of endogenous LC3 was detected with immunofluorescence microscopy. MSCs were pretreated with 3-MA (10 mM), LY294002 (LY, 10 *μ*M) or Wortmannin (WM, 200 nM) for 1 h before poly(I:C) transfection (HMW or LMW, 200 ng/ml). (**d**) Protein levels of LC3 I and LC3 II were detected with western blot at 6 h after transfection. (**e**) Cell death was measured by using an MTT assay at 24 h after transfection. MSCs were transfected with siBeclin1 or siNC for 48 h, followed by poly(I:C) transfection (HMW or LMW, 200 ng/ml). (**f**) The conversion of LC3 and cleavage of Caspase-3 and PARP were detected by western blot at 6 h after poly(I:C) transfection. (**g**) Cell death was measured by using an MTT assay at 24 h after poly(I:C) transfection. MTT data are shown as mean±S.E.M. of three independent experiments. NS, not significant](cddis2013504f6){#fig6}
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